TY - JOUR
T1 - Impfungen bei Immundefekten/Immunsuppression - Expertenstatement und Empfehlungen
AU - Wiedermann, Ursula
AU - Sitte, Harald H
AU - Burgmann, Heinz
AU - Eser, Alexander
AU - Falb, Petra
AU - Holzmann, Heidemarie
AU - Kitchen, Maria
AU - Köller, Marcus
AU - Kollaritsch, Herwig
AU - Kundi, Michael
AU - Lassmann, Hans
AU - Mutz, Ingomar
AU - Pickl, Winfried F
AU - Riedl, Elisabeth
AU - Sibilia, Maria
AU - Thalhammer, Florian
AU - Tucek, Barbara
AU - Zenz, Werner
AU - Zwiauer, Karl
N1 - Publisher Copyright:
© 2016, The Author(s).
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Immunosuppression of various origins is associated with an increased risk of infection; therefore the prevention of infectious diseases by vaccination is especially important in immunocompromised patients. However, the response to vaccinations is often reduced in these risk groups and the application of live vaccines is contraindicated during immunosuppression.In the following expert statement, recommendations for vaccination were created on the basis of current evidence and theoretical/immunological considerations. A first, general part elaborates on efficacy and safety of vaccinations during immunosuppression, modes of action of immunosuppressive medications and recommended time intervals between immunosuppressive treatments and vaccinations. A core piece of this part is a graduation of immunosuppression into three stages, i. e. no relevant immunosuppression, mild to moderate and severe immunosuppression and the assignment of various medications (including biologicals) to one of those stages; this is followed by an overview of possible and necessary vaccinations in each of those stages.The second part gives detailed vaccination guidelines for common diseases and therapies associated with immunosuppression. Primary immune deficiencies, chronic kidney disease, diabetes mellitus, solid and hematological tumors, hematopoetic stem cell transplantation, transplantation of solid organs, aspenia, rheumatological-, gastroenterologic-, dermatologic-, neurologic diseases, biologicals during pregnancy and HIV infection are dealt with.These vaccination guidelines, compiled for the first time in Austria, aim to be of practical help for physicians to facilitate and improve vaccination coverage in immunocompromised patients and their household members and contact persons.
AB - Immunosuppression of various origins is associated with an increased risk of infection; therefore the prevention of infectious diseases by vaccination is especially important in immunocompromised patients. However, the response to vaccinations is often reduced in these risk groups and the application of live vaccines is contraindicated during immunosuppression.In the following expert statement, recommendations for vaccination were created on the basis of current evidence and theoretical/immunological considerations. A first, general part elaborates on efficacy and safety of vaccinations during immunosuppression, modes of action of immunosuppressive medications and recommended time intervals between immunosuppressive treatments and vaccinations. A core piece of this part is a graduation of immunosuppression into three stages, i. e. no relevant immunosuppression, mild to moderate and severe immunosuppression and the assignment of various medications (including biologicals) to one of those stages; this is followed by an overview of possible and necessary vaccinations in each of those stages.The second part gives detailed vaccination guidelines for common diseases and therapies associated with immunosuppression. Primary immune deficiencies, chronic kidney disease, diabetes mellitus, solid and hematological tumors, hematopoetic stem cell transplantation, transplantation of solid organs, aspenia, rheumatological-, gastroenterologic-, dermatologic-, neurologic diseases, biologicals during pregnancy and HIV infection are dealt with.These vaccination guidelines, compiled for the first time in Austria, aim to be of practical help for physicians to facilitate and improve vaccination coverage in immunocompromised patients and their household members and contact persons.
KW - Allergy and Immunology/standards
KW - Austria
KW - Contraindications
KW - Humans
KW - Immunocompromised Host
KW - Immunosuppressive Agents/administration & dosage
KW - Vaccination
KW - Vaccines/administration & dosage
KW - vaccination schedules
KW - live vaccines
KW - multiple sclerosis
KW - timing
KW - cancer patients
KW - biologicals
KW - Graduation of immunosuppression
KW - rheumatic disease
KW - contraindication
UR - http://www.scopus.com/inward/record.url?scp=84979544398&partnerID=8YFLogxK
U2 - 10.1007/s00508-016-1033-6
DO - 10.1007/s00508-016-1033-6
M3 - Artikel in Fachzeitschrift
C2 - 27457874
SN - 0043-5325
VL - 128 Suppl 4
SP - 337
EP - 376
JO - Wiener Klinische Wochenschrift
JF - Wiener Klinische Wochenschrift
ER -